قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Danaher is buying GE Life Sciences bio pharma business for $ 21.4 billion

Danaher is buying GE Life Sciences bio pharma business for $ 21.4 billion



Danaher will buy the biopharmaceutical business of General Electric in a $ 21.4 billion deal, the companies announced on Monday. [Div] group> p: first-child "/>

The deal will see Danaher pay $ 21 trillion in cash, as well as certain certain GE pension liabilities.

The GE Life Sciences unit will join Danaher's Life Science as a standalone business. ] "We are executing on our strategy by taking thoughtful and deliberate action to reduce leverage and strengthen our balance sheet," GE Chairman and CEO Larry Culp said in a statement.

GE shares jumped more than 10 percent in premarket trading from Friday's close of $ 1

0.17 a share Danaher's stock also increased higher, rising 2.2 percent from its previous close of $ 113.48 a share.

This story is expected to be completed by the fourth quarter of this year.

This story is developing . Please check back for updates.


Source link